Publications & Works

Publication Network
Articles 96
All (96)
SCI-E, SSCI, AHCI (87)
SCI-E, SSCI, AHCI, ESCI (89)
ESCI (1)
Scopus (86)
TRDizin (3)
Other Publications (3)

1. Improved Bioavailability of Spironolactone–Hydroxypropyl-β-Cyclodextrin Complex Tablets Evaluated in Rat Model

DEMİRTÜRK E., Gundogdu G., ÇETİN M., BİLENSOY E.
Journal of Pharmaceutical Innovation , vol.21, no.5, 2026 (SCI-Expanded, Scopus) Creative Commons License identifier

2. CD44-targeted cyclodextrin-hyaluronic acid nanoparticles carrying gemcitabine and paclitaxel to pancreatic cancer

VARAN G., Demirtürk N., Gökşen S., Benito J. M., Malanga M., ÖZTÜRK S. C., et al.
European Journal of Pharmaceutical Sciences , vol.221, 2026 (SCI-Expanded, Scopus) identifier identifier

3. 3D printed intrauterine device development containing dual anticancer drugs for the treatment of uterine cancer

VARAN C., AKSÜT D., ŞEN M., BİLENSOY E.
European Journal of Pharmaceutical Sciences , vol.219, 2026 (SCI-Expanded, Scopus) identifier identifier

4. Paclitaxel loaded human serum albumin nanoparticles, from batch to microfluidics: A smart manufacturing approach for nab-paclitaxel nanosimilar candidate and in vitro head-to-head comparison

Cobanoglu E., VARAN C., VARAN G., BİLENSOY E.
Journal of Drug Delivery Science and Technology , vol.115, 2026 (SCI-Expanded, Scopus) identifier

5. A novel injectable nanotherapeutic platform increasing the bioavailability and anti-tumor efficacy of Arachidonylcyclopropylamide on an ectopic non-small cell lung cancer xenograft model: A randomized controlled trial

Boyacioglu O., VARAN C., BİLENSOY E., Aykut Z. G., REÇBER T., NEMUTLU E., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.670, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

6. 2-AG-loaded and bone marrow-targeted PCL nanoparticles as nanoplatforms for hematopoietic cell line mobilization

KÖSE S., VARAN C., Onen S., NEMUTLU E., BİLENSOY E., Korkusuz P.
STEM CELL RESEARCH & THERAPY , vol.15, no.1, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

7. Optimization and characterization of Rituximab targeted multidrug loaded cyclodextrin nanoparticles against Non-Hodgkin Lymphoma

Demirturk N., VARAN G., KAĞA S., Malanga M., BİLENSOY E.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.662, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

8. Cyclodextrin polymers containing ionizable and ionic groups: A comprehensive review from classifications and synthesis methods to applications

Kashani E., Maghsoudi S., Rezania H., Yarazavi M., Hajiabbas M., Benkovics G., et al.
MATERIALS TODAY CHEMISTRY , vol.39, 2024 (SCI-Expanded, Scopus) identifier identifier

9. Open forum conference on the ICH M13A bioequivalence guideline

Blume H., Wedemeyer S., Seidlitz A., Beuerle G., Klein S., BİLENSOY E.
European Journal of Pharmaceutical Sciences , vol.196, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

10. Design and Characterization of Carboplatin and Paclitaxel Loaded PCL Filaments for 3D Printed Controlled Release Intrauterine Implants

Varan C., Aksüt D., Şen M., Bilensoy E.
PHARMACEUTICS , vol.15, no.4, pp.1-17, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

11. Oral docetaxel delivery with cationic polymeric core-shell nanocapsules: In vitro and in vivo evaluation

Daşkın D., Erdoğar N., İSKİT A. B., BİLENSOY E.
Journal of Drug Delivery Science and Technology , vol.80, 2023 (SCI-Expanded, Scopus) identifier identifier

12. Is there a niche for zinc oxide nanoparticles in future drug discovery?

BİLENSOY E., VARAN C.
Expert Opinion on Drug Discovery , vol.18, no.9, pp.943-945, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

13. Insight into oral amphiphilic cyclodextrin nanoparticles for colorectal cancer: comprehensive mathematical model of drug release kinetic studies and antitumoral efficacy in 3D spheroid colon tumors

ÜNAL S., VARAN G., Benito J. M., AKTAŞ Y., BİLENSOY E.
Beilstein Journal of Organic Chemistry , vol.19, pp.139-157, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

14. Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines

Şenol Y., KAPLAN O., VARAN C., Demirtürk N., Öncül S., Fidan B. B., et al.
Journal of Drug Delivery Science and Technology , vol.79, 2023 (SCI-Expanded, Scopus) Sustainable Development identifier identifier

15. Nanocarriers targeting the diseases of the pancreas

Demirturk N., BİLENSOY E.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.170, pp.10-23, 2022 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

16. Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model

Unal S., ÖZTÜRK S. C., BİLGİÇ E., Yanik H., KORKUSUZ P., AKTAŞ Y., et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.169, pp.168-177, 2021 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

17. Q-tof lc/ms-based untargeted metabolomics approach to evaluate the effect of folate-conjugated cyclodextrins on triple-negative breast cancer cells

Varol I., KAPLAN O., Erdoğar N., Öncül S., Nielsen T. T., ERCAN A., et al.
Current Pharmaceutical Analysis , vol.17, no.10, pp.1272-1281, 2021 (SCI-Expanded, Scopus) Sustainable Development identifier identifier

18. A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers

Akkin S., VARAN G., BİLENSOY E.
MOLECULES , vol.26, no.11, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

19. Development of oral aprepitant-loaded chitosan-polyethylene glycol-coated cyclodextrin nanocapsules: formulation, characterization, and pharmacokinetic evaluation

Erdogar N., Akkin S., Nielsen T. T., Ozcelebi E., Erdogdu B., NEMUTLU E., et al.
JOURNAL OF PHARMACEUTICAL INVESTIGATION , vol.51, no.3, pp.297-310, 2021 (SCI-Expanded, Scopus) identifier identifier

20. Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level

ERCAN A., ÇELEBİER M., ÖNCÜL S., VARAN G., KOÇAK E., Benito J. M., et al.
International Journal of Pharmaceutics , vol.598, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

21. Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver

Varan G., Demirturk N., Benito J. M., BİLENSOY E.
Journal of Drug Targeting , vol.29, no.4, pp.439-453, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

22. Determination and validation of aprepitant in rat plasma using LC-MS/MS.

Erdogar N., REÇBER T., B Iskit A. B., BİLENSOY E., KIR S., NEMUTLU E.
Bioanalysis , vol.13, no.5, pp.363-372, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

23. Therapeutic efficacy and biodistribution of paclitaxel-bound amphiphilic cyclodextrin nanoparticles: Analyses in 3D tumor culture and tumor-bearing animals in vivo

Varan G., Varan C., Öztürk S. C., Benito J. M., Esendağlı G., Bilensoy E.
Nanomaterials , vol.11, no.2, pp.1-18, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

24. ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro.

Boyacioglu O., BİLGİÇ E., VARAN C., BİLENSOY E., NEMUTLU E., GÜLMEZ SEVİM D., et al.
Cell death & disease , vol.12, no.1, pp.56, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

25. Printers and Printing Technologies in the Pharmaceutical Field Yazıcılar ve Baskı Teknolojilerinin Farmasötik Alanda Kullanımı

Çobanoğlu E., VARAN C., BİLENSOY E.
Fabad Journal of Pharmaceutical Sciences , vol.46, no.1, pp.43-78, 2021 (Scopus) identifier

26. Erlotinib complexation with randomly methylated beta-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer

Erdogar N., Akkin S., VARAN G., BİLENSOY E.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , vol.26, pp.797-806, 2021 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

27. Preparation and characterization of cyclodextrin nanosponges for organic toxic molecule removal

VARAN C., Anceschi A., Sevli S., Bruni N., Giraudo L., BİLGİÇ E., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.585, 2020 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

28. Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization

ÜNAL S., AKTAŞ Y., Benito J. M., BİLENSOY E.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.584, 2020 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

29. Improved oral bioavailability of anticancer drug tamoxifen through complexation with water soluble cyclodextrins: in vitro and in vivo evaluation

Erdoğar N., NEMUTLU E., İSKİT A. B., KARA Ş. A., Teksin Z. Ş., BİLENSOY E.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY , vol.96, no.1-2, pp.81-91, 2020 (SCI-Expanded, Scopus) identifier identifier

30. Mechanical characterization and ex vivo evaluation of anticancer and antiviral drug printed bioadhesive film for the treatment of cervical cancer

Varan C., Şen M., Sandler N., Aktaş Y., Bilensoy E.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.130, pp.114-123, 2019 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

31. The effect of Quercus coccifera L. Extract on the Necrosis of Random-pattern Skin Flaps in Rats Quercus coccifera L. Ekstresinin Random Patern Deri Flebi Nekrozu Üzerine Etkisi

Orhan E., Aka İ. Ö., Yüzbaşıoğlu M., Yavuz B., BİLENSOY E., Uz A.
Haseki Tip Bulteni , vol.57, no.3, pp.249-254, 2019 (Scopus, TRDizin) Creative Commons License identifier identifier

32. Plant-Based Natural Polymeric Nanoparticles as Promising Carriers for Anticancer Therapeutics

Varan G., VARAN C., BİLENSOY E.
POLYMERIC NANOPARTICLES AS A PROMISING TOOL FOR ANTI-CANCER THERAPEUTICS , pp.293-318, 2019 (SCI-Expanded) identifier

33. Cyclodextrin-Based Nanosystems: Current Status and Future Prospects

VARAN C., Varan G., Erdogar N., BİLENSOY E.
DRUG DELIVERY NANOSYSTEMS: FROM BIOINSPIRATION AND BIOMIMETICS TO CLINICAL APPLICATIONS , pp.29-58, 2019 (SCI-Expanded) identifier

34. Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells

ERCAN A., ÇELEBİER M., VARAN G., ÖNCÜL S., Nenni M., KAPLAN O., et al.
European Journal of Pharmaceutical Sciences , vol.123, pp.377-386, 2018 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

35. The effect of Arnebia purpurea extract on the survival of random pattern skin flaps in rats

ORHAN A. E., YÜZBAŞIOĞLU M., EROL Y. R., BİLENSOY E., ERDOĞAR N., DEMİREZER L. Ö., et al.
The European Research Journal , vol.4, pp.152-156, 2018 (TRDizin) Creative Commons License

36. Cellular interaction and tumoral penetration properties of cyclodextrin nanoparticles on 3D breast tumor model

Varan G., Patrulea V., Borchard G., BİLENSOY E.
Nanomaterials , vol.8, no.2, 2018 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

37. Cyclodextrin-based polymeric nanosystems

Erdogar N., Varan G., VARAN C., BİLENSOY E.
DRUG TARGETING AND STIMULI SENSITIVE DRUG DELIVERY SYSTEMS , pp.715-748, 2018 (SCI-Expanded) identifier

38. Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer

ERDOĞAR N., ESENDAĞLI G., Nielsen T. T., Esendagli-Yilmaz G., Yoyen-Ermis D., Erdogdu B., et al.
JOURNAL OF DRUG TARGETING , vol.26, no.1, pp.66-74, 2018 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

39. Nanocapsules for drug delivery: An updated review of the last decade

Erdoğar N., Akkin S., BİLENSOY E.
Recent Patents on Drug Delivery and Formulation , vol.12, no.4, pp.252-266, 2018 (Scopus) identifier identifier

40. Cyclodextrin-Based Nanosystems in Targeted Cancer Therapy

Erdogar N., BİLENSOY E.
CYCLODEXTRIN APPLICATIONS IN MEDICINE, FOOD, ENVIRONMENT AND LIQUID CRYSTALS , vol.17, pp.59-80, 2018 (SCI-Expanded) identifier

41. Amphiphilic cyclodextrin nanoparticles

VARAN G., VARAN C., ERDOĞAR N., Hincal A. A., BİLENSOY E.
International Journal of Pharmaceutics , vol.531, no.2, pp.457-469, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

42. Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration

VARAN C., WİCKSTRÖM H., SANDLER N., AKTAŞ Y., BİLENSOY E.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.531, no.2, pp.701-713, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

43. Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment

VARAN C., BİLENSOY E.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY , vol.8, pp.1446-1456, 2017 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

44. Amphiphilic cyclodextrin derivatives for targeted drug delivery to tumors

ERDOĞAR N., VARAN G., BİLENSOY E.
Current Topics in Medicinal Chemistry , vol.17, no.13, pp.1521-1528, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

45. Localized delivery of methylprednisolone sodium succinate with polymeric nanoparticles in experimental injured spinal cord model

KARABEY-AKYUREK Y., GURCAY A. G., GURCAN O., TURKOGLU O. F., Yabanoglu-Ciftci S., EROĞLU H., et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , vol.22, no.8, pp.972-981, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

46. Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery

Varan G., Benito J. M., Mellet C. O., BİLENSOY E.
Beilstein Journal of Nanotechnology , vol.8, no.1, pp.1457-1468, 2017 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

47. An Improved and Validated HPLC Method for the Determination of Methylprednisolone Sodium Succinate and its Degradation Products in Nanoparticles

KARABEY-AKYUREK Y., NEMUTLU E., BİLENSOY E., ÖNER L.
CURRENT PHARMACEUTICAL ANALYSIS , vol.13, no.2, pp.162-168, 2017 (SCI-Expanded, Scopus) identifier identifier

48. Cholesterol-Targeted Anticancer and Apoptotic Effects of Anionic and Polycationic Amphiphilic Cyclodextrin Nanoparticles

VARAN G., ÖNCÜL S., ERCAN A., BENITO J. M., MELLET C. O., BİLENSOY E.
Journal of Pharmaceutical Sciences , vol.105, no.10, pp.3172-3182, 2016 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

49. Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles

ERDOĞAR N., ESENDAĞLI G., Nielsen T. T., ŞEN M., ÖNER L., BİLENSOY E.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.509, pp.375-390, 2016 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

50. Siklodekstrinler ve Biyomedikal AlandakiUygulamaları

ÇELEN N., BİLENSOY E., ÇALIŞ S.
Hacettepe University Journal of the Faculty Pharmacy , 2016 (Peer-Reviewed Journal)

51. Cyclodextrins and their applications in biomedical field Siklodekstrinler ve Biyomedikal Alandaki Uygulamaları

Çelen N., BİLENSOY E., ÇALIŞ S.
Hacettepe University Journal of the Faculty of Pharmacy , vol.36, no.1, pp.50-69, 2016 (Scopus) identifier

52. Amphiphilic cyclodextrins as enabling excipients for drug delivery and for decades of scientific collaboration: Tribute to a distinguished scientist, French representative and friend - A historical perspective

AKTAŞ Y., Yenice I., BİLENSOY E., HINCAL A. A.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.30, pp.261-265, 2015 (SCI-Expanded, Scopus) identifier identifier

53. Antitumor Efficacy of Bacillus Calmette-Guerin Loaded Cationic Nanoparticles for Intravesical Immunotherapy of Bladder Tumor Induced Rat Model

ERDOĞAR N., İSKİT A. B., EROĞLU H., SARGON M. F., Mungan N. A., BİLENSOY E.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY , vol.15, no.12, pp.10156-10164, 2015 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

54. Role of Nanoparticles in the Treatment of Noninvasive Bladder Cancer

BİLENSOY E., Erdogar N., Mungan A. N.
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.14, no.1, pp.61-66, 2015 (ESCI, TRDizin) Creative Commons License Sustainable Development identifier

55. Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin

UNAL H., Ozturk N., BİLENSOY E.
Beilstein Journal of Organic Chemistry , vol.11, pp.204-212, 2015 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

56. Core-shell hybrid nanocapsules for oral delivery of camptothecin: formulation development, in vitro and in vivo evaluation

UNAL H., D'ANGELO I., PAGANO E., BORRELLI F., IZZO A., UNGARO F., et al.
JOURNAL OF NANOPARTICLE RESEARCH , vol.17, no.1, 2015 (SCI-Expanded, Scopus) identifier identifier

57. Cationic polymer nanoparticles for drug and gene delivery

BİLENSOY E., Işik G., VARAN C.
RSC Polymer Chemistry Series , no.13, pp.268-295, 2015 (SCI-Expanded) identifier identifier

58. Amphiphilic Cyclodextrin Nanoparticles for Effective and Safe Delivery of Anticancer Drugs

Bilensoy E.
GENEDIS 2014: NEURODEGENERATION , vol.822, pp.201, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

59. Binary, ternary and microencapsulated celecoxib complexes with beta-cyclodextrin formulated via hydrophilic polymers

Vranic E., Grizic D., Planinsek O., Srcic S., BİLENSOY E.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY , vol.80, pp.139-146, 2014 (SCI-Expanded, Scopus) Sustainable Development identifier identifier

60. Development of implantable hydroxypropyl-beta-cyclodextrin coated polycaprolactone nanoparticles for the controlled delivery of docetaxel to solid tumors

VARAN C., BİLENSOY E.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY , vol.80, pp.9-15, 2014 (SCI-Expanded, Scopus) Sustainable Development identifier identifier

61. Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: Safety and efficacy

ERDOĞAR N., İSKİT A. B., EROĞLU H., SARGON M. F., Mungan N. A., BİLENSOY E.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.471, pp.1-9, 2014 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

62. Wound healing activity of the Bellis perennis L. (common daisy)

Karakas F. P., Karakas A., Boran C., Turker A. U., YALÇIN F. N., BİLENSOY E.
NEW BIOTECHNOLOGY , vol.29, 2012 (SCI-Expanded, Scopus) identifier

63. Prolonged retention and in vivo evaluation of cationic nanoparticles loaded with Mitomycin C designed for intravesical chemotherapy of bladder tumours

Erdogar N., İSKİT A. B., Mungan N. A., BİLENSOY E.
Journal of Microencapsulation , vol.29, no.6, pp.576-582, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

64. The evaluation of topical administration of Bellis perennis fraction on circular excision wound healing in Wistar albino rats

Karakaş F. P., Karakaş A., Boran Ç., Türker A. U., YALÇIN F. N., BİLENSOY E.
Pharmaceutical Biology , vol.50, no.8, pp.1031-1037, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

65. Rapamycin-cyclodextrin complexation: Improved solubility and dissolution rate

Abdur Rouf M., VURAL İ., BİLENSOY E., Hincal A., Erol D. D.
Journal of Inclusion Phenomena and Macrocyclic Chemistry , vol.70, pp.167-175, 2011 (SCI-Expanded) identifier identifier

66. Preface

BİLENSOY E.
Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications , 2011 (SCI-Expanded) identifier identifier identifier

67. A double-blind placebo-controlled study of 5-fluorouracil: Cyclodextrin complex loaded thermosensitive gel for the treatment of HPV induced condyloma

BİLENSOY E., Moroy P., Çırpanlı Y., Bilensoy T., ÇALIŞ S., Mollamahmutoglu L.
Journal of Inclusion Phenomena and Macrocyclic Chemistry , vol.69, pp.309-313, 2011 (SCI-Expanded) identifier identifier

68. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model

Çirpanli Y., Allard E., Passirani C., Bilensoy E., Lemaire L., Çaliş S., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.403, pp.201-206, 2011 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

69. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(ε-caprolactone) and chitosan nanoparticles

Cirpanli Y., Yerlikaya F., Ozturk K., Erdogar N., Launay M., Gegu C., et al.
Pharmazie , vol.65, no.12, pp.867-870, 2010 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

70. An alternative cyclodextrin based formulation for oral anticancer drug exemestane: In vitro and cell culture studies.

Yavuz B., Sarisözen C., Vural İ., Bilensoy E., Sumnu M.
Journal of controlled release : official journal of the Controlled Release Society , vol.148, no.1, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

71. Preparation and characterization of cationic nanoparticles loaded with Mitomycin C by double emulsion and ionotropic gelation techniques.

Erdoǧar N., Mungan A., Bilensoy E.
Journal of controlled release : official journal of the Controlled Release Society , vol.148, no.1, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

72. Alternative oral exemestane formulation: Improved dissolution and permeation

Yavuz B., BİLENSOY E., VURAL İ., Sumnu M.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.398, pp.137-145, 2010 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

73. Development of polymeric and cyclodextrin nanoparticles for camptothecin delivery.

Cirpanli Y., Bilensoy E., Dogan A. L., Calis S.
Journal of controlled release : official journal of the Controlled Release Society , vol.148, no.1, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

74. Cationic nanoparticles for cancer therapy

BİLENSOY E.
Expert Opinion on Drug Delivery , vol.7, no.7, pp.795-809, 2010 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

75. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles

BİLENSOY E., Hincal A. A.
Expert Opinion on Drug Delivery , vol.6, no.11, pp.1161-1173, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

76. Antibacterial activity of triclosan chitosan coated graft on hernia graft infection model

Çakmak A., Çirpanli Y., Bilensoy E., Yorganci K., Çaliş S., Saribaş Z., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.381, no.2, pp.214-219, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

77. ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF TAMOXIFEN CITRATE USING NORMAL PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Yerlikaya F., Launay M., Gegu C., Leturgez T., BİLENSOY E., ÇALIŞ S., et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.38, no.1, pp.183-184, 2009 (SCI-Expanded) identifier

78. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery

Çirpanli Y., Bilensoy E., Lale Doǧan A., Çaliş S.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.73, no.1, pp.82-89, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

79. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors

Bilensoy E., Sarisozen C., Esendagli G., Doğan A., Aktas Y., Şen M., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.371, pp.170-176, 2009 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

80. Nanoparticulate delivery systems based on amphiphilic cyclodextrins

BİLENSOY E.
Journal of Biomedical Nanotechnology , vol.4, no.3, pp.293-303, 2008 (SCI-Expanded, Scopus) identifier identifier

81. Hyaluronic acid coated poly-ε-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea

Yenice I., Mocan M. C., PALASKA E., Bochot A., BİLENSOY E., VURAL İ., et al.
Experimental Eye Research , vol.87, no.3, pp.162-167, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

82. Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel

Bilensoy E., Gurkaynak O., Ertan M., Şen M., Hincal A. A.
JOURNAL OF PHARMACEUTICAL SCIENCES , vol.97, pp.1519-1529, 2008 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

83. Safety and efficacy of amphiphilic ß-cyclodextrin nanoparticles for paclitaxel delivery

BİLENSOY E., Gürkaynak O., DOĞAN A., Hincal A. A.
International Journal of Pharmaceutics , vol.347, pp.163-170, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

84. Bioavailability File: Exemestane

YAVUZ B., BİLENSOY E., Sumnu M.
FABAD J. Pharm. Sci. , vol.32, no.2, pp.79-89, 2007 (Peer-Reviewed Journal)

85. Complexation behavior of antiestrogen drug tamoxifen citrate with natural and modified beta-cyclodextrins

Bilensoy E., Dogan L., Sen M., Hincal A.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY , vol.57, pp.651-655, 2007 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

86. Thermosensitive mucoadhesive gel formulation loaded with 5-Fu: cyclodextrin complex for HPV-induced cervical cancer

Bilensoy E., Cirpanli Y., Sen M., Dogan A. L., Calis S.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY , vol.57, pp.363-370, 2007 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier

87. Analytical Method Validation for HPLC Assay of Oral Anticancer Drug Exemestane

YAVUZ B., BİLENSOY E., Sumnu M.
FABAD J. Pharm. Sci , vol.32, no.1, pp.15-22, 2007 (Peer-Reviewed Journal)

88. Cytotoxic evaluation of injectable cyclodextrin nanoparticles

Memisoglu-Bilensoy E., DOĞAN A., Hincal A. A.
Journal of Pharmacy and Pharmacology , vol.58, no.5, pp.585-589, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

89. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex

Bilensoy E., Rouf M. A., Vural İ., Sen M., Hincal A. A.
AAPS PharmSciTech , vol.7, no.2, 2006 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

90. Sterile, injectable cyclodextrin nanoparticles: Effects of gamma irradiation and autoclaving

Memisoglu-Bilensoy E., Hincal A. A.
International Journal of Pharmaceutics , vol.311, pp.203-208, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

91. Effect of drug physicochemical properties on in vitro characteristics of amphiphilic cyclodextrin nanospheres and nanocapsules

Memisoglu-Bilensoy E., Sen M., Hincal A. A.
Journal of Microencapsulation , vol.23, no.1, pp.59-68, 2006 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

92. Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin.

BİLENSOY E., Rouf M., VURAL İ., Hincal A.
Journal of controlled release : official journal of the Controlled Release Society , vol.116, no.2, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

93. Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: In vitro characterization and cytotoxicity

Memisoglu-Bilensoy E., VURAL İ., Bochot A., Renoir J. M., Duchene D., Hincal A. A.
Journal of Controlled Release , vol.104, no.3, pp.489-496, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

94. Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: System development and evaluation

Memisoglu-Bilensoy E.
European Journal of Pharmaceutical Sciences , vol.25, 2005 (SCI-Expanded, Scopus) identifier

95. Transcription efficiency of tamoxifen citrate-loaded β-cyclodextrin nanoparticles

VURAL İ., Memisoglu-Bilensoy E., Renoir J., Bochot A., Duchêne D., Hincal A.
Journal of Drug Delivery Science and Technology , vol.15, no.5, pp.339-342, 2005 (SCI-Expanded, Scopus) identifier

96. Amphiphilic beta-cyclodextrins modified on the primary face: Synthesis, characterization, and evaluation of their potential as novel excipients in the preparation of nanocapsules

Memisoglu E., Bochot A., Sen M., Charon D., Duchene D., Hincal A.
JOURNAL OF PHARMACEUTICAL SCIENCES , vol.91, no.5, pp.1214-1224, 2002 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 35

1. Development and Characterization of Erlotinib-Randomly Methylated-β-cyclodextrin Complex for the Treatment of Non-small Lung Cancer

ERDOĞDU N., Akkın S., VARAN G., BİLENSOY E.
13th Internation symposium of Pharmaceutical Science, Ankara, Turkey, 22 - 25 June 2021, (Full Text)

2. Farelerde Tamoksifen ve Majör Metaboliti N-Desmetil-Tamoksifen’in LC- MS/MS Yöntemiyle Tayini

ERDOĞAR N., NEMUTLU E., KIR S., İSKİT A. B., BİLENSOY E.
XVI. Ulusal Spektroskopi Kongresi, Turkey, 7 - 09 November 2019, (Full Text)

3. Cannabinoid Receptor 1-Mediated Antiproliferative Effect of ACPA and ACPA-PCL Controlled Release System on Non-Small Cell Lung Cancer Lines

BOYACIOĞLU Ö., BİLGİÇ E., VARAN C., BİLENSOY E., NEMUTLU E., KARAOSMANOĞLU B., et al.
EACR Conference Nanotechnology in Cancer: Engineering for Oncology, Cambridge, Canada, 12 - 14 September 2019, (Summary Text) Sustainable Development

4. Development of a new antiproliferative arachydonoylcyclopropilamide (ACPA) releasing nanoparticle-based drug for endometrial cancers by targeting cannabinoid 1 receptors

BİLGİÇ E., BOYACIOĞLU Ö., VARAN C., BİLENSOY E., NEMUTLU E., KARAOSMANOĞLU B., et al.
EACR Conference Nanotechnology in Cancer: Engineering for Oncology, 12 - 14 September 2019, (Summary Text) Sustainable Development

5. A Metabolomic Study to Investigate the Effect of Folate Conjugated Nanoparticles on Triple Negative Breast Cancer Cells

ERCAN A., ÇELEBİER M., varol ı., KAPLAN O., Varan G., ÖNCÜL S., et al.
EUFEPS Annual Meeting 2019 PERSONALIZED MEDICINES,TARGETED THERAPIES,PRECISION DRUG DELIVERY, 6 - 08 March 2019, (Full Text) Sustainable Development

6. Development and Characterization of Arachidonoylcyclopropilamide-Loaded Polycaprolactone Nanoparticle Drug Formulation

BOYACIOĞLU Ö., BİLGİÇ E., VARAN C., BİLENSOY E., NEMUTLU E., KORKUSUZ P.
24th International Biomedical Science Technology Symposium, 17 - 20 October 2019, (Summary Text)

7. The effect of polycationic amphiphilic cyclodestrin nanoparticles on mda-mb cancer cells: A metabolomic approach to understand the mechanism

ÇELEBİER M., KAPLAN O., VARAN G., ÖNCÜL S., KOÇAK E., ERCAN A., et al.
12 th International symposium on pharmaceutical sciences, 26 June 2018, (Summary Text) Sustainable Development

8. GENOMIC AND METABOLOMIC STUDIES OF POLYCATIONIC AMPHIPHILIC CYCLODEXTRIN NANOPARTICLESON HEPG2 CELL LINE

ERCAN A., ÇELEBİER M., Varan G., ÖNCÜL S., KOÇAK E., KAPLAN O., et al.
EUFEPS Annual Meeting 2018 Crossing Barriers for Future Medicines, 24 - 26 May 2018, (Full Text)

9. Mechanical Characterization and ex vivo Evaluation of Inkjet Printed Bioadhesive Film Formulation of Complexed Paclitaxel and Nanoparticulate Cidofovir

VARAN C., ŞEN M., SANDLER N., AKTAŞ Y., BİLENSOY E.
EUFEPS Annual Meeting 2018, Atina, Greece, 24 - 26 May 2018, (Summary Text)

10. Investigation of the Effect of Cyclodextrin Nanoparticles on MCF 7 Breast Cancer Cell Line by Proteomics Approaches

BİLENSOY E., ÇELEBİER M., ERCAN A., NENNİ M., IŞIK G., ÖNCÜL S., et al.
7th BBBB International Conference on Pharmaceutical Sciences, 5 - 07 October 2017, (Full Text)

11. Printing and characterization of antiviral and anticancer drug loaded film formulation by using inkjet printer

VARAN C., ŞEN M., SANDLER N., AKTAŞ Y., BİLENSOY E.
7th BBBB International Conference on Pharmaceutical Sciences, 5 - 07 October 2017, (Summary Text)

12. Anticancer and Antiviral Drug Printed Bioadhesive Film for Cervical Cancer:Ink Formulation Development by using Cyclodextrin Derivatives

VARAN C., SANDLER N., BİLENSOY E.
5th European Cyclodextrin Conference, 3 - 06 October 2017, (Summary Text) Sustainable Development

13. Preparation and Characterization of Antiviral and Anticancer Drug Printed Film Formulations for the treatment of Cervical Cancer

VARAN C., ŞEN M., SANDLER N., BİLENSOY E.
SANKO University Innovation in Medicine Summit, 11 - 13 May 2017, (Summary Text) Sustainable Development identifier identifier identifier

14. Evaluation of Cholesterol-Targeted Amphiphilic Cyclodextrin Nanoparticles for Cancer Therapy

VARAN G., ÖNCÜL S., ERCAN A., BENİTO J., MELLET C. O., BİLENSOY E.
Innovation in Medicine Meetings III Congress, 11 - 13 May 2017, (Summary Text) Sustainable Development

15. Novel Folate-Conjugated Amphiphilic Cyclodextrin Nanoparticles For Paclitaxel Delivery in Recurrent Metastatic Breast Cancer

ERDOĞAR N., ESENDAĞLI G., NIELSEN T. T., ESENDAĞLI YILMAZ G., SARGON M. F., ÖNER L., et al.
Innovation in Medicine Summit-3, 11 - 13 May 2017, (Summary Text) Sustainable Development

16. In Vitro and In Vivo Evaluation of Tumor Targeted Nanoparticles for Paclitaxel Delivery with Folate conjugated Amphiphilic Cyclodextrin Derivatives

ERDOĞAR N., TERNDRUP N., ÖNER L., ESENDAĞLI G., BİLENSOY E.
4th European Conference on Cyclodextrins (EUROCD 2015), 6 - 09 October 2015, (Summary Text)

17. Nanoparticulate Cidofovir and Paclitaxel Cyclodextrin Complex Combination in Ink Jet Printed Adhesive Film for HPV Infection

VARAN C., SANDLER N., BİLENSOY E.
4th European Conference on Cyclodextrins, 6 - 09 October 2015, (Summary Text)

18. Cefixime oral bioavailability improved by cyclodextrin inclusion complex In vitro in vivo evaluation

ÇELEN N., ÖZTÜRK N., BİLENSOY E., ÇALIŞ S.
4th European Conference on Cyclodextrins, 6 - 09 October 2015, (Full Text)

19. Effects Of Quercus coccifera on Viability of Random Pattern Skin Flaps in Rats

ORHAN A. E., ÖZKAYA AKA İ., YÜZBAŞIOĞLU M., BİLENSOY E., YAVUZ B., UZ A.
9th BAPRAS (Balkan Association of Plastic Reconstructive And Aesthetic Surgery) Congress, + Day Aesthetic Symposium Figures and Shapes in the Balkans, 17 - 20 September 2015, pp.64, (Summary Text)

20. Optimization by 32 Factorial Design of Tumor Targeted Nanoparticles for Paclitaxel Delivery with Folate conjugated Amphiphilic Cyclodextrin

ERDOĞAR N., ÖNER L., ESENDAĞLI G., NİELSEN T., BİLENSOY E.
EUFEPS Annual Meeting, 15 - 17 June 2015

21. Preparation and characterization of Cidofovir and Paclitaxel loaded bioadhesive film for the treatment of HPV induced cervical cancer by printing technology

VARAN C., SANDLER N., AKTAŞ Y., BİLENSOY E.
EUFEPS Annual Meeting 2015, 15 - 17 June 2015, (Summary Text) Sustainable Development

22. Docetaxel loaded hydroxypropyl B cyclodextrin polycaprolactone nanoparticles formulation development and in vitro characterization

VARAN C., BİLENSOY E.
17th International Pharmaceutical Technology Symposium, 8 - 10 September 2014, (Summary Text)

23. Development of Docetaxel loaded Hydroxypropyl-β-Cylodextrin Polycaprolactone Nanoparticles for The Treatment of Solid Tumors

VARAN C., BİLENSOY E.
3rd European Conference on Cyclodextrins, 2 - 04 October 2013, (Summary Text)

24. Docetaxel-loaded cationic core-shell polycaprolactone nanoparticles designed for rat glioma model

VARAN C., BİLENSOY E.
9th Central European Symposium on Pharmaceutical Technology: CESPT 2012, 20 - 22 September 2012, (Summary Text)

25. Docetaxel-loaded core-shell polycaprolactone nanoparticles: formulation development and characterization

VARAN C., BİLENSOY E.
16th International Pharmaceutical Technology Symposium, 10 - 12 September 2012, (Summary Text)

26. Polycaprolactone nanoparticles for rat glioma model: influence of formulation parameters on the particle size and zeta potential

VARAN C., BİLENSOY E.
8th Nanoscience and Nanotechnology Congress International Academy of Nanomedine 3rd World Congress, 25 - 29 June 2012, (Summary Text)

27. Core-shell polycaprolactone nanoparticles for rat glioma model: formulation development and characterization

VARAN C., BİLENSOY E.
CRS Nordic Chapter Meeting, 3 - 05 June 2012, (Summary Text)

28. Safety and Efficacy of Amphiphilic Cyclodextrins for Drug Delivery

Hincal A. A., EROĞLU H., BİLENSOY E.
9th International Meeting of the International-Society-for-the-Study-of-Xenobiotics(ISSX), İstanbul, Turkey, 4 - 08 September 2010, vol.42, pp.12-13, (Summary Text) identifier

29. Inclusion complexation of rapamycin with beta-cyclodextrin to improve solubility and stability of the drug

Rouf M. A., Bilensoy E., Vural I., Hincal A. A.
2nd BBBB Conference on Pharmaceutical Sciences, Tartu, Estonia, 13 - 15 September 2007, vol.32, (Summary Text) identifier

30. Tumor targeted nanoparticles for cancer therapy

Bilensoy E.
2nd BBBB Conference on Pharmaceutical Sciences, Tartu, Estonia, 13 - 15 September 2007, vol.32, (Summary Text) Sustainable Development identifier

31. Stabilization of camptothecin in PLGA nanoparticles

Cirpanli Y., Bilensoy E., Calis S., Hincal A. A.
2nd BBBB Conference on Pharmaceutical Sciences, Tartu, Estonia, 13 - 15 September 2007, vol.32, (Summary Text) identifier

32. Determination of stability of rapamycin following exposure to different conditions

Rouf M. A., Bilensoy E., Vural I., Hincal A. A.
2nd BBBB Conference on Pharmaceutical Sciences, Tartu, Estonia, 13 - 15 September 2007, vol.32, (Summary Text) identifier

33. Bioadhesive coated poly-epsilon-caprolactone nanoparticles loaded with Mitomycin C for the treatment of superficial bladder tumors

Sarisozen C., Aktas Y., Mungan A., Bilensoy E.
2nd BBBB Conference on Pharmaceutical Sciences, Tartu, Estonia, 13 - 15 September 2007, vol.32, (Summary Text) identifier

34. Formulation of poorly water soluble drugs with amphiphilic beta cyclodextrins

Hincal A., Bilensoy E.
18th Helsinki Drug Research, Helsinki, Finland, 1 - 02 June 2006, vol.28, (Summary Text) identifier

35. Targeted nanoparticles for cancer therapy

Bilensoy E.
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.35, (Summary Text) Sustainable Development identifier
Books 8

1. Role of Polymers Used in Nanoparticles for Controlled Drug Delivery

Dag S. S., VARAN C., BİLENSOY E.
in: Novel Drug Delivery Approaches: From Fundamentals to Advanced Carrier Systems, CRC Press, pp.94-107, 2026 identifier

2. Biodistribution of polymeric, polysaccharide and metallic nanoparticles

Erdoğdu N., Varan G., Varan C., Bilensoy E.
in: Characterization of Pharmaceutical Nano- and Microsystems, Peltonen Leena,Douroumis Dennis,Fahr Alfred,Siepmann Jurgen,Snowden Martin J., Editor, John Wiley & Sons, West Sussex, UK , Cambridge, pp.275-290, 2020 identifier

3. Cyclodextrin Based Nano-Systems: Current Status and Future Prospects

VARAN C., VARAN G., ERDOĞAR N., BİLENSOY E.
in: Drug Delivery Nanosystems: From Bioinspiration and Biomimetics to Clinical Applications, Pippa Natassa, Demetzos Costas, Pispas Stergios, Editor, Pan Stanford, pp.29-49, 2019

4. Plant based natural polymer (Guar gum, pectin, starch, cellulose, cyclodextrins) nanoparticles as promising tool for anticancer therapeutics

VARAN G., VARAN C., BİLENSOY E.
in: Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics, Prashant Kesharwani, Kishore M. Paknikar, Virendra Gajbhiye, Editor, Academic Press, 2019 Sustainable Development

5. Cyclodextrin-Based Nanosystems in Targeted Cancer Therapy

ERDOĞAR N., BİLENSOY E.
in: Cyclodextrin Applications in Medicine, Food, Environment and Liquid Crystals, Gregorio Crini, Eric Lichtfouse, Sophie Fourmentin, Editor, Springer, Cham, pp.59-80, 2018

6. Cyclodextrin-based polymeric nanosystems

ERDOĞAR N., VARAN G., VARAN C., BİLENSOY E.
in: Drug Targeting and Stimuli Sensitive Drug Delivery Systems, Alina M. Holban, Editor, William Andrew, pp.715-748, 2018 identifier

7. Dozaj Şekilleri

ÇAPAN Y., SAVAŞER A., KANTARCI A. G., KARATAŞ A., ARICA YEGİN B., HASÇİÇEK C., et al.
in: Türk Farmakopesi 2017-II, Dr. ALİ ALKAN, ERAY KAPLAN, OĞUZHAN KOYUNCU, SELİN ERGÜN AYAN, Editor, SAĞLIK BAKANLIĞI, Ankara, pp.969-1014, 2018

8. Cationic polymer nanoparticles for drug and gene delivery

BİLENSOY E., IŞIK G., VARAN C.
in: Cationic Polymers in Regenerative Medicine, Samal Sangram K., Dubruel Peter, Editor, Royal Society of Chemistry, 2015 identifier identifier identifier
Metrics

Publication

156

Publication (WoS)

101

Publication (Scopus)

91

Citation (WoS)

3000

H-Index (WoS)

32

Citation (Scopus)

3370

H-Index (Scopus)

34

Citation (Scholar)

4205

H-Index (Scholar)

37

Citation (Sobiad)

98

H-Index (Sobiad)

4

Project

46

Thesis Advisory

10

Open Access

18
UN Sustainable Development Goals